ydgC Antibody

Shipped with Ice Packs
In Stock

Product Specs

Buffer
Preservative: 0.03% ProClin 300; Constituents: 50% Glycerol, 0.01M Phosphate Buffered Saline (PBS), pH 7.4
Form
Liquid
Lead Time
14-16 week lead time (made-to-order)
Synonyms
ydgC; Z2608; ECs2313; Inner membrane protein YdgC
Target Names
ydgC
Uniprot No.

Target Background

Database Links

KEGG: ece:Z2608

STRING: 155864.Z2608

Subcellular Location
Cell inner membrane; Multi-pass membrane protein.

Q&A

What is ydgC and what is its biological significance?

ydgC is a bacterial protein found in gram-negative bacteria, particularly in Escherichia coli (strain K12) and Shigella flexneri. It functions as a component involved in lipopolysaccharide (LPS) assembly pathways . LPS is a critical constituent of the outer membrane of gram-negative bacteria that contributes to membrane integrity, bacterial survival, and pathogenesis.

Understanding ydgC is particularly important in:

  • Bacterial cell envelope biogenesis research

  • Membrane protein organization studies

  • Investigations of bacterial stress responses

  • Research on antimicrobial resistance mechanisms

What are the validated research applications for ydgC antibodies?

Based on manufacturer specifications, commercially available ydgC antibodies have been validated for:

ApplicationValidation StatusTypical Dilution Range
Western Blot (WB)Validated1:500 - 1:2000
ELISAValidated1:1000 - 1:5000

These antibodies are primarily used in bacterial research settings focusing on membrane biology, stress responses, and bacterial adaptation mechanisms .

How specific are ydgC antibodies across different bacterial species?

Commercial ydgC antibodies show species-specific reactivity patterns:

Antibody CatalogTarget OrganismCross-ReactivityUniProt Reference
CSB-PA364875XA01ENVE. coli (K12)Limited to closely related EnterobacteriaceaeP0ACX0
CSB-PA364876XA01SZBShigella flexneriPrimary reactivity with Shigella strainsP0ACX2

While these antibodies were raised against specific bacterial species, researchers should validate cross-reactivity when studying related bacterial strains . Sequence homology analysis suggests potential cross-reactivity within the Enterobacteriaceae family, but experimental validation is required for each research application.

What methodologies are recommended for validating ydgC antibody specificity?

Comprehensive validation of ydgC antibodies should follow these sequential steps:

  • Genetic validation: Test antibody reactivity in wild-type vs. ydgC knockout or knockdown bacterial strains

  • Peptide competition assays: Pre-incubate antibody with excess recombinant ydgC protein (provided as positive control with commercial antibodies) to confirm signal reduction

  • Multiple antibody approach: Compare results using antibodies from different suppliers or those targeting different epitopes

  • Orthogonal techniques: Correlate antibody-based detection with mRNA expression or mass spectrometry data

Following YCharOS open antibody characterization principles, researchers should document validation results methodically and consider sharing validation data with the research community .

How can researchers optimize ydgC antibody performance in membrane protein studies?

Membrane proteins like ydgC present unique technical challenges that require specialized approaches:

  • Sample preparation optimization:

    • Compare multiple lysis buffers containing different detergents (Triton X-100, CHAPS, DDM)

    • Evaluate sonication vs. enzymatic vs. mechanical disruption methods

    • Test subcellular fractionation protocols to enrich membrane components

  • Signal enhancement strategies:

    • Employ signal amplification systems like tyramide signal amplification for immunodetection

    • Consider protein enrichment via immunoprecipitation before analysis

    • Optimize blocking conditions to reduce background (5% BSA typically superior to milk for membrane proteins)

  • Technical controls:

    • Include recombinant ydgC protein as positive control

    • Use pre-immune serum (provided with antibody) as negative control

    • Compare results across different bacterial growth phases

How can ydgC antibodies contribute to understanding bacterial stress responses?

ydgC is implicated in LPS assembly, which undergoes significant remodeling during bacterial stress responses . Researchers can leverage ydgC antibodies to:

  • Quantify expression changes:

    • Monitor ydgC protein levels under stress conditions including:

      • Antibiotic exposure (particularly cell wall targeting agents)

      • pH stress

      • Osmotic stress

      • Nutrient limitation

  • Track subcellular localization:

    • Employ fractionation followed by immunoblotting to detect redistribution during stress

    • Consider immunofluorescence microscopy when optimized protocols are established

  • Identify binding partners:

    • Use co-immunoprecipitation with ydgC antibodies followed by mass spectrometry

    • Evaluate changes in protein-protein interactions under different stress conditions

What are the optimal Western blot protocols for detecting ydgC?

Recommended Western Blot Protocol:

  • Sample preparation:

    • Harvest bacteria in mid-log phase (OD600 ≈ 0.6-0.8)

    • Resuspend in lysis buffer containing:

      • 50 mM Tris-HCl pH 7.5

      • 150 mM NaCl

      • 1% Triton X-100 or 1% DDM

      • Protease inhibitor cocktail

    • Disrupt cells via sonication (6 × 10s pulses with 10s cooling)

    • Clarify lysate (14,000 × g, 15 min, 4°C)

  • Gel electrophoresis:

    • Load 20-40 μg total protein per lane

    • Use 12-15% SDS-PAGE (ydgC is a relatively small protein)

    • Include recombinant antigen as positive control

  • Transfer conditions:

    • Semi-dry transfer: 15V for 30 min

    • Or wet transfer: 100V for 1 hour in cold room

  • Immunodetection:

    • Block with 5% BSA in TBST (1 hour, room temperature)

    • Primary antibody: 1:1000 dilution in 2.5% BSA/TBST (overnight, 4°C)

    • Wash 3× with TBST

    • Secondary antibody: Anti-rabbit HRP 1:5000 (1 hour, room temperature)

    • Wash 3× with TBST

    • Develop using standard chemiluminescence

What considerations are important for ELISA applications with ydgC antibodies?

Optimized ELISA Protocol:

  • Plate preparation:

    • Coat 96-well plates with bacterial lysate (10 μg/mL) or purified recombinant ydgC (1-2 μg/mL) in carbonate buffer (pH 9.6)

    • Incubate overnight at 4°C

    • Wash 3× with PBST

  • Blocking and antibody incubation:

    • Block with 3% BSA in PBST (2 hours, room temperature)

    • Add primary antibody at 1:2000 dilution (2 hours, room temperature)

    • Wash 5× with PBST

    • Add HRP-conjugated anti-rabbit antibody at 1:5000 (1 hour, room temperature)

    • Wash 5× with PBST

  • Detection:

    • Add TMB substrate and monitor color development

    • Stop reaction with 2N H₂SO₄

    • Read absorbance at 450 nm

  • Controls and optimization:

    • Include standard curve with recombinant ydgC protein

    • Test antibody titration (1:1000 to 1:10,000)

    • Compare different blocking agents (BSA vs. casein)

    • Validate specificity with competitive inhibition using recombinant protein

What are the best practices for storage and handling of ydgC antibodies?

To maximize antibody stability and performance:

  • Storage conditions:

    • Store concentrated antibody stocks at -20°C or -80°C as recommended by manufacturer

    • Avoid repeated freeze-thaw cycles by preparing single-use aliquots

    • For working solutions, store at 4°C with 0.02% sodium azide for up to 2 weeks

  • Handling recommendations:

    • Keep on ice during experimental procedures

    • Add carrier protein (0.1% BSA) to diluted antibodies for enhanced stability

    • Use low-protein binding tubes for storage

    • Centrifuge briefly before opening to collect solution at tube bottom

  • Quality control practices:

    • Include positive controls in each experiment to monitor antibody performance

    • Document lot numbers and maintain consistency within projects

    • Perform regular validation assays to monitor antibody performance over time

    • Consider antibody titration experiments for each new lot

How can ydgC antibodies be used in conjunction with other research tools?

Complementary approaches enhance the value of ydgC antibody-based research:

  • Multi-omics integration:

    • Correlate protein levels (detected by antibodies) with transcriptomics data

    • Combine with metabolomics to assess impact of ydgC alterations on bacterial metabolism

    • Integrate with structural biology approaches to understand protein-protein interactions

  • Advanced microscopy applications:

    • Super-resolution microscopy to determine precise subcellular localization

    • Live-cell imaging using fluorescently labeled nanobodies derived from ydgC antibodies

    • FRET-based approaches to study ydgC interactions with other membrane components

  • Systems biology approaches:

    • Network analysis combining antibody-based protein quantification with other datasets

    • Pathway analysis incorporating ydgC interaction partners

    • Mathematical modeling of membrane assembly incorporating ydgC dynamics

What are the considerations for applying antibody engineering concepts to improve ydgC antibody performance?

Modern antibody engineering approaches can enhance research applications:

  • Affinity maturation:

    • In vitro evolution techniques can enhance binding affinity without sacrificing specificity

    • Directed mutagenesis of complementarity-determining regions (CDRs)

    • Selection strategies using phage or yeast display

  • Format optimization:

    • Generation of Fab fragments for improved tissue penetration and reduced background

    • Development of single-chain variable fragments (scFvs) for specialized applications

    • Creation of bispecific formats targeting ydgC and interacting partners simultaneously

  • Functionality enhancement:

    • Site-specific conjugation strategies for fluorophores or enzymes

    • Modification of framework regions to increase stability

    • Glycoengineering approaches to optimize performance in specific applications

How might ydgC antibodies contribute to bacterial pathogenesis research?

Given ydgC's role in membrane biology, these antibodies offer valuable tools for studying host-pathogen interactions:

  • Virulence studies:

    • Examine ydgC expression during different stages of infection

    • Compare ydgC levels between virulent and attenuated strains

    • Correlate ydgC expression with antibiotic resistance profiles

  • Host-pathogen interaction analysis:

    • Investigate ydgC regulation during host cell attachment/invasion

    • Study ydgC expression changes in response to host immune factors

    • Evaluate ydgC as a potential diagnostic marker for bacterial infections

  • Therapeutic discovery applications:

    • Screen for compounds that modulate ydgC expression or function

    • Evaluate ydgC as a potential antibacterial target

    • Develop detection systems for bacterial identification based on ydgC antibodies

How does antibody validation for bacterial targets compare to mammalian applications?

Bacterial protein detection presents unique challenges compared to mammalian targets:

ConsiderationBacterial Targets (e.g., ydgC)Mammalian Targets
Specificity validationRequires testing in knockout strains; challenging in some speciesEstablished knockout cell lines often available
Cross-reactivityMust consider bacterial species diversitySpecies cross-reactivity often well-characterized
Sample preparationCell wall disruption critical; detergent selection importantGenerally standardized protocols exist
Background issuesBacterial components can cause non-specific bindingWell-established blocking protocols
Expression systemsCareful consideration of tags that may affect membrane localizationVariety of validated systems available

Researchers should apply the comprehensive validation framework established by YCharOS but adapt protocols specifically for bacterial targets .

How should researchers address common technical challenges with ydgC antibodies?

IssuePossible CausesRecommended Solutions
Weak or no signal in Western blot- Insufficient protein extraction
- Low antibody concentration
- Protein degradation
- Optimize lysis with membrane-specific detergents
- Increase antibody concentration
- Add additional protease inhibitors
High background- Insufficient blocking
- Antibody concentration too high
- Non-specific binding
- Increase blocking time/concentration
- Titrate antibody
- Try alternative blocking agents (BSA vs. milk)
Multiple bands- Cross-reactivity
- Protein degradation
- Post-translational modifications
- Validate with recombinant control
- Use fresh samples with protease inhibitors
- Compare with predicted molecular weight
Inconsistent results- Batch-to-batch variation
- Sample preparation differences
- Growth condition variations
- Use consistent antibody lots
- Standardize sample preparation
- Control bacterial growth conditions carefully

How can researchers interpret complex ydgC expression patterns across experimental conditions?

When analyzing ydgC expression data:

  • Quantification approaches:

    • Use densitometry with appropriate normalization controls

    • Consider multiple housekeeping controls specific for bacterial systems

    • Apply statistical analysis appropriate for the experimental design

  • Expression pattern analysis:

    • Correlate ydgC expression with phenotypic changes

    • Consider post-translational modifications affecting antibody recognition

    • Evaluate subcellular distribution changes alongside total expression

  • Experimental design considerations:

    • Include time-course experiments to capture dynamic changes

    • Compare multiple bacterial strains under identical conditions

    • Control for growth phase effects on membrane protein expression

What standards should be applied when publishing research using ydgC antibodies?

To ensure reproducibility in the scientific literature, researchers should:

  • Antibody reporting standards:

    • Provide complete antibody information (supplier, catalog number, lot, RRID)

    • Include detailed validation data specific to experimental conditions

    • Document all optimization steps and final protocol parameters

  • Controls documentation:

    • Describe all positive and negative controls used

    • Include validation experiments demonstrating specificity

    • Provide full blots/images with molecular weight markers in supplementary materials

  • Method transparency:

    • Detail all buffer compositions

    • Specify exact incubation times and temperatures

    • Document image acquisition and analysis parameters

    • Share raw data in appropriate repositories

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.